Cargando…
Dual bronchodilators in Bronchiectasis study (DIBS): protocol for a pragmatic, multicentre, placebo-controlled, three-arm, double-blinded, randomised controlled trial studying bronchodilators in preventing exacerbations of bronchiectasis
INTRODUCTION: Bronchiectasis is a long-term lung condition, with dilated bronchi, chronic inflammation, chronic infection and acute exacerbations. Recurrent exacerbations are associated with poorer clinical outcomes such as increased severity of lung disease, further exacerbations, hospitalisations,...
Autores principales: | Morton, Miranda, Wilson, Nina, Homer, Tara Marie, Simms, Laura, Steel, Alison, Maier, Rebecca, Wason, James, Ternent, Laura, Abouhajar, Alaa, Allen, Maria, Joyce, Richard, Hildreth, Victoria, Lakey, Rachel, Cherlin, Svetlana, Walker, Adam, Devereux, Graham, Chalmers, James D, Hill, Adam T, Haworth, Charles, Hurst, John R, De Soyza, Anthony |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423789/ https://www.ncbi.nlm.nih.gov/pubmed/37562935 http://dx.doi.org/10.1136/bmjopen-2023-071906 |
Ejemplares similares
-
Effects of long-term bronchodilators in bronchiectasis patients with airflow limitation based on bronchodilator response at baseline
por: Jeong, Ho Jung, et al.
Publicado: (2016) -
Latrophilin receptors: novel bronchodilator targets in asthma
por: Faiz, A, et al.
Publicado: (2017) -
Multidimensional severity assessment in bronchiectasis: an analysis of seven European cohorts
por: McDonnell, M J, et al.
Publicado: (2016) -
Area Under the Expiratory Flow–Volume Curve (AEX): Assessing Bronchodilator Responsiveness
por: Ioachimescu, Octavian C., et al.
Publicado: (2020) -
Prognostic performance of the FACED score and bronchiectasis severity index in bronchiectasis: a systematic review and meta-analysis
por: He, Min, et al.
Publicado: (2020)